What to Do When Tricare Denies Wegovy: Appeal Strategy

Introduction

Tricare denied your Wegovy® prescription, and you want to know what is actually appealable and what is not. The short answer: Tricare covers Wegovy when prior authorization criteria are met, and most denials are PA failures that can be fixed with better documentation. Categorical exclusions are rare but exist.

This article walks through the Tricare-specific appeal process, the medical necessity criteria the program uses, and the SELECT trial framing that increasingly flips weight-management denials into approvals. It pulls from Tricare Pharmacy Policy guidance updated through 2026 and SELECT trial outcomes (Lincoff et al. 2023 NEJM).

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

Why Did Tricare Deny My Wegovy Prescription?

Tricare denials for Wegovy usually fall into three categories: PA criteria not met, step therapy not completed, or non-formulary status. PA criteria failures are the most common and the most appealable.

Quick Answer: Tricare covers Wegovy when PA criteria are met (BMI 30+ or 27+ with comorbidity)

Tricare’s standard PA criteria for Wegovy include BMI 30+, or BMI 27+ with at least one comorbidity (type 2 diabetes, hypertension, hyperlipidemia, OSA, or established cardiovascular disease), documented six-month lifestyle modification attempt, and sometimes a prior trial of an older anti-obesity medication.

If your denial cites “PA not met,” the appeal needs to identify which specific criterion was not documented in the original submission and provide the documentation now. If the denial cites “non-formulary,” the appeal needs a non-formulary exception request, which is a different process.

What Does the Tricare Appeal Process Look Like?

Tricare appeals have two formal levels. Level 1 is a reconsideration filed with the pharmacy contractor (Express Scripts for most Tricare plans). Level 2 is a formal appeal to the Defense Health Agency.

Level 1 reconsideration must be filed within 90 days of the denial. Express Scripts has 60 days to respond. If denied again, you have 90 days to file the Level 2 appeal.

Level 2 appeals go to a different reviewer than Level 1 and are decided based on the written record. You can request a personal appearance for complex cases, but most appeals are resolved on documents.

How Do I File a Level 1 Tricare Reconsideration?

Submit a written request to Express Scripts with the denial reference, the appeal reason, and supporting documentation. The request can be mailed, faxed, or submitted through the Express Scripts portal.

Include the denial letter, the original prescription, your letter of medical necessity, two years of relevant medical records, prior weight-loss attempt documentation, and any comorbidity workup (lipid panel, A1c, sleep study, CV imaging).

The reconsideration request itself should be no more than two pages. State the denial reference, list your medical conditions with ICD-10 codes, cite the FDA indication and supporting trial, and request specific resolution (approval, peer-to-peer, or formulary exception).

What Does the Letter of Medical Necessity Need to Say?

The letter is the single most influential document in the file. It needs to come from a Tricare-credentialed prescriber and state the indication, diagnosis codes, prior treatment history, and clinical rationale.

Name Wegovy and semaglutide 2.4 mg specifically. State the FDA indication being claimed (chronic weight management OR cardiovascular risk reduction in established CVD). List all comorbidities with ICD-10 codes. Document prior weight-loss attempts with dates, dosages, and outcomes. Cite STEP 1 (Wilding et al. 2021 NEJM, 14.9% mean weight loss at 68 weeks) or SELECT (Lincoff et al. 2023 NEJM, 20% MACE reduction).

The letter should not be longer than one page. Tricare reviewers see hundreds of these. Clinical specificity wins over volume.

How Does the SELECT Cardiovascular Indication Change the Appeal?

The FDA approved Wegovy in March 2024 for cardiovascular risk reduction in adults with established cardiovascular disease and obesity or overweight. For Tricare patients with prior MI, stroke, or PAD, this indication is often easier to approve than weight management.

The SELECT trial enrolled patients aged 45+ with BMI 27+ and established CV disease. It showed a 20% reduction in major adverse cardiovascular events over a mean 39-month follow-up. The number needed to treat to prevent one MACE event was 67.

If you have any qualifying CV history, the appeal should lead with the SELECT indication. Tricare’s PA criteria for the CV indication include documented established CVD (prior MI, stroke, PAD, or CABG/PCI history), BMI 27+, and prescriber attestation that secondary prevention is the goal.

What Is Peer-to-peer Review and When Should I Request It?

Peer-to-peer review is a phone consultation between your prescriber and a clinical reviewer at Express Scripts. It is optional and often resolves cases that fail on paper review.

Your prescriber requests the peer-to-peer by phone or through the Express Scripts portal. The call typically lasts 10-15 minutes. The reviewer either approves on the call or commits to a written decision within 5-7 business days.

Peer-to-peer is most useful when the clinical picture is nuanced. If your patient has marginal BMI but multiple comorbidities, or partial prior treatment trials, a live conversation can convey the context that a written file misses.

Key Takeaway: First-level appeals must be filed within 90 days of denial

Do Active Duty Service Members Face Different Rules?

Yes. Active duty members are subject to readiness criteria that retirees and dependents are not. Wegovy can affect deployment status, weight standards compliance, and physical readiness testing.

Active duty appeals usually require coordination with the member’s military treatment facility (MTF) and may need MTF pharmacy approval rather than Express Scripts approval. The PA criteria are similar but include deployment readiness considerations.

Retirees, dependents, and Tricare for Life beneficiaries follow the standard civilian-style PA process through Express Scripts. No deployment readiness review applies.

What If Both Level 1 and Level 2 Appeals Deny?

You have three remaining options: external review through the Federal Tort Claims Act process (rare and slow), switching to a covered medication, or cash-pay through a compounding provider.

Covered alternatives on Tricare’s formulary include phentermine, orlistat, and naltrexone-bupropion. None match Wegovy’s STEP 1 efficacy of 14.9% mean weight loss, but they are accessible at standard Tricare copays.

Cash-pay compounded semaglutide is the third option. TrimRx offers a free assessment quiz that screens eligibility and connects qualifying patients with licensed providers for a personalized treatment plan including compounded semaglutide.

What Documentation Strengthens a Tricare Wegovy Appeal?

Six categories of documentation make the strongest appeals. First, the original prescription with diagnosis code (E66.01 obesity, E66.811 obesity with hypoventilation, or relevant cardiovascular codes). Second, the denial letter with reason code visible.

Third, two years of medical records showing weight trajectory, comorbidity diagnoses, and prior treatment attempts. Fourth, lab values: lipid panel, A1c, complete metabolic panel, and TSH within the last 12 months. Fifth, prior weight-loss attempt documentation including phentermine or orlistat trials, dietitian visits, military weight programs, and commercial programs with dates and outcomes.

Sixth, the letter of medical necessity. This is the most influential single document. It should name Wegovy and semaglutide 2.4 mg, state the FDA indication being claimed, list all comorbidities by ICD-10 code, cite specific trial data (STEP 1, SELECT), and document prior treatment failures.

How Does Express Scripts Review the Appeal?

Express Scripts assigns a pharmacist or pharmacy technician to review the initial submission. Standard reviews take up to 60 days. The reviewer applies Tricare-specific PA criteria from the current policy manual.

Common review outcomes: approve (PA criteria fully documented), approve with limits (specific dose or quantity restriction), defer to peer-to-peer review (clinical case requires prescriber discussion), or deny with specific reason cited. Each outcome has a different next step for the patient.

If denied at Level 1, you have 90 days to file the Level 2 formal appeal. Level 2 reviews go to a different reviewer and to the Defense Health Agency level. The decision is based on the written record by default, but you can request personal appearance for complex cases.

Bottom line: Active duty members face stricter criteria than retirees and dependents

FAQ

How Long Does a Tricare Wegovy Appeal Take?

Level 1 reconsideration takes up to 60 days. Level 2 formal appeal takes another 60-90 days. Expedited appeals for urgent medical situations resolve within 72 hours.

Does Tricare Cover Wegovy for Active Duty Members?

Yes, but with additional readiness considerations. Active duty members typically need MTF pharmacy approval rather than Express Scripts approval.

Can My Civilian PCP Write the Letter of Medical Necessity?

Yes, if they are Tricare-credentialed. Non-credentialed prescribers can still write the letter, but the prescription itself must come from a credentialed provider.

Does Tricare Cover Compounded Semaglutide?

No. Tricare does not cover compounded medications. Compounded semaglutide is cash-pay only.

What Is the Tricare Copay for Wegovy When Approved?

Copays vary by plan. Tricare Select copay for non-formulary brand drugs runs $40-60 per 30-day supply. Tricare Prime copays are lower.

Can I Get Wegovy Through a Military Pharmacy?

Yes, if approved. MTF pharmacies dispense Wegovy when the PA is approved and the prescription routes through the military pharmacy system. Active duty members are usually required to fill at MTF when stocked.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.